Neurogenic Thoracic Outlet Syndrome: A Primer for Hand and Peripheral Nerve Surgeons.

J Hand Surg Am

Department of Orthopaedic Surgery, Musculoskeletal Education and Research Center, Carilion Clinic Institute for Orthopaedics and Neurosciences, Roanoke, VA. Electronic address:

Published: June 2024

Neurogenic thoracic outlet syndrome is a complex condition and is commonly misunderstood. Historically, much of this confusion has been because of its grouping with other diagnoses that have little in common other than anatomic location. Modern understanding emphasizes the role of small unmyelinated C type pain and sympathetic fibers. Diagnosis is primarily clinical, after ruling out other common conditions. Hand therapy is usually the first-line treatment with variable success. Local anesthetic, botulinum toxins, or steroid injections can aid in diagnosis and offer short-term relief. Although surgery can yield reliable results, it is technically challenging, and the preferred surgical approach is a matter of debate. Despite limitations in diagnosis and treatment, recognition and successful treatment of this condition can be highly impactful for the patient.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhsa.2023.11.027DOI Listing

Publication Analysis

Top Keywords

neurogenic thoracic
8
thoracic outlet
8
outlet syndrome
8
syndrome a primer
4
a primer hand
4
hand peripheral
4
peripheral nerve surgeons
4
nerve surgeons neurogenic
4
syndrome complex
4
complex condition
4

Similar Publications

Anterior cord syndrome is a rare yet critical neurological condition that poses significant challenges in clinical management. We present the case of a 71-year-old male with a medical history of hypertension, uncontrolled type II diabetes mellitus, hypothyroidism, and end-stage renal disease requiring dialysis who presented to the emergency department with complaints of chills, back pain, abdominal pain, and vomiting episodes. Based on the severity of the patient's illness, it was decided that inpatient admission would be best.

View Article and Find Full Text PDF

The occurrence of neurogenic tumors in the tracheobronchial tree is uncommon. We report a case of transmural tracheal schwannoma with extraluminal component extending upto the left thyroid lobe. 40-year-old male presented with scanty hemoptysis due to transmural tracheal schwannoma with extraluminal part of tumor extending till the left lobe of thyroid gland.

View Article and Find Full Text PDF

Are handheld dynamometers a valid alternative to isokinetic devices for assessing the shoulder rotators in neurogenic thoracic outlet syndrome?

Ann Phys Rehabil Med

January 2025

Service de Médecine Physique et Réadaptation Locomotrice et Respiratoire, CHU Nantes, Nantes Université, 85 rue Saint Jacques, 44093 Nantes, Cedex 1, France; Service de Médecine du Sport, CHU Nantes, Nantes Université, 85 rue Saint Jacques, 44093 Nantes, Cedex 1, France; Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, ONIRIS, Nantes Université, 1 place Alexis Ricordeau, 44000 Nantes Cedex 1, France; Institut Européen de la Main, Hôpital Kirchberg, 9, rue Edward Steichen, L-254 Luxembourg, Luxembourg; Medical Training Center, Hôpital Kirchberg, L2540 Luxembourg, Luxembourg; Institut Régional de Médecine du Sport (IRMS), 85 rue Saint Jacques, 44093 Nantes, Cedex 1, France. Electronic address:

View Article and Find Full Text PDF

Thymomas have been associated with the generation of paraneoplastic autoantibodies to neurogenic epitopes, collapsin-response-mediator protein-5 receptor (CRMP-5) and alpha-amino-3-hydroxyl-5methyl-4isoxazolepropionic acid receptor (AMPAR), in patients with acute viral infection. We report a patient with thymoma and myasthenia gravis, with SARS-CoV-2 infection, who became comatose secondary to autoimmune encephalitis. Plasmapheresis, high-dose steroids, pyridostigmine, eculizumab, and rituximab did not restore neurologic function.

View Article and Find Full Text PDF

A novel molecular classification for small cell lung cancer (SCLC) has been established utilizing the transcription factors achaete-scute homologue 1 (ASCL1), neurogenic differentiation factor 1 (NeuroD1), POU class 2 homeobox 3 (POU2F3), and yes-associated protein 1 (YAP1). This classification was predicated on the transcription factors. Conversely, there is a paucity of information regarding the distribution of these markers in other subtypes of pulmonary neuroendocrine tumors (PNET).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!